Abstract
Wenliang Ma
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Stroke
10.1016/s0140-6736(24)00642-1 · 2024
Secondary prevention after ischemic stroke
10.1056/nejmcp2415601 · 2026
Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis
10.1016/s2666-7568(23)00217-9 · 2024
Ischemia and reperfusion--from mechanism to translation
10.1038/nm.2507 · 2011
Inflammatory responses after ischemic stroke
10.1007/s00281-022-00943-7 · 2022
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
10.1038/s41392-023-01688-x · 2024
The bibliometric and visualized analysis on cancer stem cells in the early 21st century
10.1097/js9.0000000000003368 · 2026
Parkinson’s disease diagnosis using deep learning: a bibliometric analysis and literature review
10.1016/j.arr.2024.102285 · 2024
Physical activity, sedentary behaviour, and cognitive function among older adults: a bibliometric analysis from 2004 to 2024
10.1016/j.arr.2024.102283 · 2024
Research hotspots and frontiers of stem cells in stroke: a bibliometric analysis from 2004 to 2022
10.3389/fphar.2023.1111815 · 2023
Bibliometric insights into the inflammation and mitochondrial stress in ischemic stroke
10.1016/j.expneurol.2024.114845 · 2024
A bibliometric analysis of T cell and atherosclerosis
10.3389/fimmu.2022.948314 · 2022
Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace
10.1517/14712598.2012.674507 · 2012
VOSviewer and Bibliometrix
10.5195/jmla.2022.1434 · 2022
Comprehensive bibliometric analysis of stem cell research in Alzheimer’s disease from 2004 to 2022
10.1159/000528886 · 2023
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis
10.1016/s1474-4422(09)70236-4 · 2009
Prevalence and risk factors of cerebral microbleeds - the Rotterdam scan Study
10.1212/01.wnl.0000307750.41970.d9 · 2008
Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis
10.1002/ana.23944 · 2013
Statin safety and associated adverse events: a scientific statement from the American Heart Association
10.1161/atv.0000000000000073 · 2019
Post-stroke dementia - a comprehensive review
10.1186/s12916-017-0779-7 · 2017
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford vascular Study
10.1016/s1474-4422(18)30442-3 · 2019
The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment
10.1111/j.1532-5415.2005.53221.x · 2005
Strategic infarct location for post-stroke cognitive impairment: a multivariate lesion-symptom mapping study
10.1177/0271678x17728162 · 2018
Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke
10.1212/wnl.0000000000006506 · 2018
Predictors of cognitive impairment after stroke: a prospective stroke cohort study
10.3233/jad-190382 · 2019
Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts
10.1016/s1474-4422(21)00060-0 · 2021
Post-stroke cognitive impairment: epidemiology, risk factors, and management
10.3233/jad-215644 · 2022
Quantifying the rise and fall of scientific fields
10.1371/journal.pone.0270131 · 2022
Evaluation methods and empirical research on comprehensiveness, accuracy and timeliness of early access indexing in the web of science
10.1177/01655515251379429 · 2025
Research trends and hotspots of post-stroke cognitive impairment: a bibliometric analysis
10.3389/fphar.2023.1184830 · 2023
Knowledge domain and emerging trends in post-stroke cognitive impairment: a bibliometric analysis
10.3389/fnagi.2025.1525626 · 2025
The role of IL-6 in ischemic stroke
10.3390/biom15040470 · 2025
The impact of cytokines in neuroinflammation-mediated stroke
10.1016/j.cytogfr.2024.06.002 · 2024
Interleukins and ischemic stroke
10.3389/fimmu.2022.828447 · 2022
Associations of soluble inflammatory and endothelial activation biomarkers with cognitive function over three years after ischemic stroke-PROSCIS-B
10.1007/s12975-025-01388-4 · 2025
Inflammatory markers and their association with post stroke cognitive decline
10.1111/ijs.12001 · 2015
The significance of interleukin-6 and tumor necrosis factor-alpha levels in cognitive impairment among first-ever acute ischaemic stroke patients
2021
C-reactive protein and T3: new prognostic factors in acute ischemic stroke
10.1016/j.jstrokecerebrovasdis.2018.05.047 · 2018
The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke
10.1080/00207454.2018.1538139 · 2019
Peripheral immunity is associated with cognitive impairment after acute minor ischemic stroke and transient ischemic attack
10.1038/s41598-024-67172-w · 2024
Machine learning-based model for prediction of post-stroke cognitive impairment in acute ischemic stroke: a cross-sectional study
10.4103/ni.ni_987_21 · doi-reference
Development and validation of a novel model to predict post-stroke cognitive impairment within 6 months after acute ischemic stroke
10.3389/fneur.2024.1451786 · doi-reference
Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months
10.18632/aging.203507 · doi-reference
The Oxford cognitive screen (OCS) as an acute predictor of long-term functional outcome in a prospective sample of stroke patients
10.1016/j.cortex.2023.04.015 · doi-reference
The Oxford cognitive screen (OCS): validation of a stroke-specific short cognitive screening tool
10.1037/pas0000082 · doi-reference
Using MemTrax memory test to screen for post-stroke cognitive impairment after ischemic stroke: a cross-sectional study
10.3389/fnhum.2023.1195220 · doi-reference
Impact of small vessel disease progression on long-term cognitive and functional changes after stroke
10.1212/wnl.0000000000200005 · doi-reference
Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack
10.1017/s1041610213002457 · doi-reference
MoCA and MMSE for the detection of post-stroke cognitive impairment: a comparative diagnostic test accuracy systematic review and meta-analysis
10.1007/s00415-025-13146-5 · doi-reference
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · doi-reference
Precision medicine in stroke: towards personalized outcome predictions using artificial intelligence
10.1093/brain/awab439 · doi-reference
Post-stroke cognitive impairment and dementia
10.1161/circresaha.122.319951 · doi-reference
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
10.1186/s13195-025-01815-6 · doi-reference
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 2021
10.1016/s1474-4422(24)00038-3 · doi-reference
The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is associated with early-onset post-stroke cognitive impairment
10.1007/s10072-022-06414-z · doi-reference
Low HALP (hemoglobin, albumin, lymphocyte, and platelet) score increases the risk of post-stroke cognitive impairment: a multicenter cohort study
10.2147/cia.s432885 · doi-reference
Lactate dehydrogenase-to albumin ratio (LAR) is associated with early-onset cognitive impairment after acute ischemic stroke
10.1016/j.jocn.2022.10.004 · doi-reference